Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | TP53 | P04637 | 4/20 | 0.59 |
| ▸ | CCR1 | P32246 | 3/20 | 0.59 |
| ▸ | CCR5 | P51681 | 3/20 | 0.59 |
| ▸ | CCR8 | P51685 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | ALPL | P05186 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | ALPG | P10696 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | METAP1 | P53582 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31275638 | 0.90 | KDM4E (0.67) | KDM4ELMNATP53CCR1CCR5 | |
| SCHEMBL1089189 | 0.89 | ALDH1A1 (0.55) | KDM4ELMNATP53CCR1CCR5 | |
| SCHEMBL29707169 | 0.88 | KDM4E (0.52) | KDM4ELMNATP53CCR1CCR5 | |
| SCHEMBL21365377 | 0.88 | KDM4E (0.52) | KDM4ELMNATP53CCR1CCR5 | |
| Dipyridyl SCHEMBL9872270 | 0.87 | KDM4E (0.67) | KDM4ELMNATP53CCR1CCR5 | |
| SCHEMBL23418270 | 0.82 | ALDH1A1 (0.54) | KDM4ELMNATP53SMN1; SMN2ALOX15 | |
| SCHEMBL29484745 | 0.82 | ALDH1A1 (0.54) | KDM4ELMNATP53SMN1; SMN2ALOX15 | |
| SCHEMBL21841064 | 0.82 | AURKA (0.47) | KDM4ELMNATP53CCR1CCR5 | |
| SCHEMBL5309600 | 0.80 | KMT2A (0.50) | KDM4ELMNATP53CCR1CCR5 | |
| SCHEMBL11992064 | 0.79 | CCR1 (0.57) | KDM4ELMNACCR1CCR8ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114621261-B | Based on [ Cu ] 4I Cl 4 ]Process for preparing polypyridyl complexes | 安阳师范学院 | 2023-08-15 | — | — | CN | claimed |
| CN-114621261-A | Based on [ Cu ]4ICl4]Process for preparing polypyridyl complexes | 安阳师范学院 | 2022-06-14 | — | — | CN | claimed |
| CN-117202987-A | Microcapsules based on acetoacetyl polymers | 弗门尼舍有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-117098598-A | Crosslinked core-shell microcapsules | 弗门尼舍有限公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-114621261-B | Based on [ Cu ] 4I Cl 4 ]Process for preparing polypyridyl complexes | 安阳师范学院 | 2023-08-15 | — | — | CN | disclosed |
| CN-114621261-B | Based on [ Cu ] 4I Cl 4 ]Process for preparing polypyridyl complexes | 安阳师范学院 | 2023-08-15 | — | — | CN | disclosed |
| CN-114621261-A | Based on [ Cu ]4ICl4]Process for preparing polypyridyl complexes | 安阳师范学院 | 2022-06-14 | — | — | CN | disclosed |
| CN-114621261-A | Based on [ Cu ]4ICl4]Process for preparing polypyridyl complexes | 安阳师范学院 | 2022-06-14 | — | — | CN | disclosed |
| WO-2021224809-A1 | PROLINE HYDROXYLASE INHIBITORS FOR USE IN THE SKELETAL MUSCLE REGENERATION | POLICLINICO SAN DONATO S.P.A. - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO (IT) | 2021-11-11 | — | — | WO | disclosed |
| US-10781226-B2 | Photoactivatable cancer prodrug | TEXAS STATE UNIVERSITY (US) | 2020-09-22 | — | — | US | disclosed |
| US-20200239503-A1 | PHOTOACTIVATABLE CANCER PRODRUG | TEXAS STATE UNIVERSITY | 2020-07-30 | — | — | US | disclosed |
| US-9273002-B2 | Benzo[k]fluoranthene derivative and organic electroluminescence device containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-03-01 | — | — | US | disclosed |
| US-9255118-B2 | Light induced drug release | UNIVERSITEIT LEIDEN (NL) | 2016-02-09 | — | — | US | disclosed |
| CN-104193628-B | Amino arone compound used as medical intermediate and synthetic method thereof | LI SHULAN (CN) | 2015-11-18 | — | — | CN | disclosed |
| CN-104193628-A | Amino arone compound used as medical intermediate and synthetic method thereof | ZHUANG WEIPING | 2014-12-10 | — | — | CN | disclosed |
| US-20140148425-A1 | LIGHT INDUCED DRUG RELEASE | UNIVERSITEIT LEIDEN (NL) | 2014-05-29 | — | — | US | disclosed |
| EP-2626346-A1 | BENZO[K]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2013-08-14 | — | — | EP | disclosed |
| US-20120211743-A1 | BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120211743-A1 | BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-08-23 | — | — | US | disclosed |
| WO-2012052821-A1 | LIGHT INDUCED DRUG RELEASE | UNIVERSITEIT LEIDEN (NL) | 2012-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148425-A1 | LIGHT INDUCED DRUG RELEASE | IK, MC1R, SUCNR1 | KDM4E 1551/4885LMNA 3061/4885TP53 3127/4885 |
| US-10781226-B2 | Photoactivatable cancer prodrug | UGT1A7, DCPS, PPOX | KDM4E 2483/4885LMNA 2803/4885TP53 75/4885 |
| US-20120211743-A1 | BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME | KCNJ2, KCNE1, KCNK2 | KDM4E 764/4885LMNA 1575/4885TP53 2879/4885 |
| US-20200239503-A1 | PHOTOACTIVATABLE CANCER PRODRUG | UGT1A7, DCPS, PPOX | KDM4E 2483/4885LMNA 2803/4885TP53 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.